Table 2. TEAEs occurring in ≥5% of patients (N=28).

AEs	n (%)
	All grades	Grade 3
TEAE, treatment-emergent adverse events. No grade 4 and 5 adverse events occurred.
Diarrhea	24 (85.7)	11 (39.3)
Vomiting	8 (28.6)	1 (3.6)
Nausea	7 (25.0)	0 (0)
Decreased appetite	5 (17.9)	0 (0)
Upper respiratory tract infections	4 (14.3)	0 (0)
Dizziness	4 (14.3)	0 (0)
White blood cell count low	3 (10.7)	0 (0)
Cough	3 (10.7)	0 (0)
Abdominal pain	3 (10.7)	0 (0)
Dyspepsia	3 (10.7)	0 (0)
Pain in extremity	2 (7.1)	0 (0)
ALT increased	2 (7.1)	0 (0)
Fatigue	2 (7.1)	0 (0)
Hypertension	2 (7.1)	0 (0)
Skin itchiness	2 (7.1)	0 (0)
Rash	2 (7.1)	0 (0)
Headache	2 (7.1)	0 (0)
Anorexia	2 (7.1)	0 (0)